Table 2.
Operative valve replacement | Trans-catheter valve replacement | p | |
---|---|---|---|
Number | 769 at 35 centers | 30 at 18 centers | |
Age at pulmonary valve replacement (years) | 17 (range: 10–61 IQR: 13–22) | 20.5 (range: 10–64, IQR: 15–28) | 0.046 |
Female Gender | 333 (43%) | 15 (50%) | 0.46 |
Race | |||
White | 574 (76%) | 19 (63%) | 0.04 |
Black | 71 (9%) | 7 (23%) | |
Asian | 25 (3%) | 2 (7%) | |
Other | 91 (12%) | 2 (7%) | |
Known genetic syndrome | 76 (10%) | 3 (10%) | 1.0 |
Payer | |||
Private insurance | 450 (59%) | 17 (57%) | 0.34 |
Medicaid | 207 (27%) | 6 (20%) | |
Other | 112 (15%) | 7 (23%) | |
Mortality | 7 (0.9%) | 0 | 1.0 |
Cost (2012US$)* | 43,877 (range: 4,399–866,720, IQR: 35,294 – 57,045) | 47,609 (range: 10,532–89,771, IQR: 35,310–72,024) | 0.45 |
Hospital length of stay (days) | 4 (range: 1–126, IQR: 3–5) | 1 (range: 1–14, IQR: 1–2) | <0.0001 |
ICU stay (days) † | 2 (range: 1–41, IQR: 2–4) | 2 (range: 1–4, IQR: 1.5–3) | 0.21 |
n=713 for SVR and n=26 for TVR
n=648 for SVR and n=8 for TVR
Abbreviations: ICU: Intensive care unit, IQR inter-quartile range, 2012US$ United States dollars adjusted for inflation to year 2012